Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase isoforms and atherosclerosis.

Orina Belton1, Desmond J Fitzgerald

  • 1Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, 123 St Stephens Green, Dublin 2, Ireland. obelton@rcsi.ie

Expert Reviews in Molecular Medicine
|February 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular vesicles derived from induced pluripotent stem cells mediate anti-inflammatory effects in primary human macrophages.

Scientific reports·2026
Same author

Tandem RNA and Protein Extraction: A Platform for Maximizing the Use of Limited Ex Vivo Tissue Samples.

Bio-protocol·2026
Same author

TRIB3 Links Endoplasmic Reticulum Stress to Impaired Efferocytosis in Atherosclerosis.

Circulation research·2025
Same author

Carbon Dioxide Sensing by Immune Cells Occurs through Carbonic Anhydrase 2-Dependent Changes in Intracellular pH.

Journal of immunology (Baltimore, Md. : 1950)·2022
Same author

Dose-Dependent Association of Inflammatory Cytokines with Carotid Atherosclerosis in Transient Ischaemic Attack: Implications for Clinical Trials.

Cerebrovascular diseases (Basel, Switzerland)·2021
Same author

Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivity.

Journal of extracellular vesicles·2021
Same journal

Harnessing the Vaginal Microbiome: A New Frontier in the Prevention of Sexually Transmitted Infections.

Expert reviews in molecular medicine·2026
Same journal

Beyond the stomach: Exploring the role of <i>Helicobacter pylori</i> in pushing precancerous lesions to colorectal cancer and the therapeutic potential of probiotics.

Expert reviews in molecular medicine·2026
Same journal

Microchimerism: The Hidden Cellular Dialogue Between Mother and Fetal That Shapes Lifelong Immunity.

Expert reviews in molecular medicine·2026
Same journal

Advances in m6A Modification in Pregnancy-Related Disorders and Female Reproductive Endocrine Diseases.

Expert reviews in molecular medicine·2026
Same journal

Dysregulation of the urea cycle - potential targets for treatment and diagnosis in prostate cancer.

Expert reviews in molecular medicine·2026
Same journal

RAGE-Mediated Signaling in Gynecological Disorders: Review of Molecular Mechanisms and Therapeutic Perspectives.

Expert reviews in molecular medicine·2026
See all related articles

Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce pain and inflammation but cause gastrointestinal issues. Selective COX-2 inhibitors (coxibs) aim to avoid these side effects but may increase cardiovascular risks, requiring further research.

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Cardiology

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for arthritis and pain relief.
  • NSAIDs inhibit cyclooxygenase (COX) enzymes, leading to prostaglandins production.
  • Long-term NSAID use is limited by gastrointestinal (GI) side effects, primarily attributed to COX-1 inhibition.

Purpose of the Study:

  • To explore the role of COX-1 and COX-2 inhibition in NSAID-induced GI toxicity and cardiovascular events.
  • To evaluate the therapeutic potential of selective COX-2 inhibitors (coxibs) in managing inflammation and pain while minimizing GI side effects.
  • To understand the complex roles of COX-1 and COX-2 in vascular regulation and their implications for atherosclerosis.

Main Methods:

  • Review of existing literature on NSAID mechanisms, GI toxicity, and cardiovascular effects.

Related Experiment Videos

  • Analysis of studies comparing traditional NSAIDs with selective COX-2 inhibitors (coxibs).
  • Examination of prostaglandin generation and COX enzyme expression in vascular disease.

    • Main Results:

    • NSAIDs inhibit both COX-1 and COX-2 enzymes, with COX-1 inhibition linked to GI toxicity and COX-2 inhibition to anti-inflammatory effects.
    • Selective COX-2 inhibitors (coxibs) were developed to reduce GI side effects but may be associated with increased cardiovascular event risk.
    • Both COX-1 and COX-2 are expressed in vascular disease, influencing prostaglandin generation, though their specific roles in vascular regulation remain under investigation.

    Conclusions:

    • Selective COX-2 inhibition offers anti-inflammatory and analgesic benefits with potentially fewer GI side effects than traditional NSAIDs.
    • Chronic coxib use may elevate the risk of cardiovascular events like atherosclerosis compared to traditional NSAIDs.
    • Further research into the specific roles of COX-1 and COX-2 in vascular health is crucial for optimizing coxib therapy and managing cardiovascular risks.